There are two scenarios UEEC could be awaiting. IMO either FDA asked for additional information and UEEC is providing it OR FDA concluded an in-person video review was not necessary and is still reviewing our original PMA "Deficiencies Letter" reply information submitted 8/16/2024. How about a PR to update us?

#475.755.1005
investor@uhpcorp.com